IFP Advisors’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
IFP Advisors's CTKB Position: Q3 2026 in Review
IFP Advisors reduced its Cytek Biosciences (CTKB) stake by 80% in Q3 2026, selling an estimated $2.26K and leaving 121 shares worth $721. The position accounts for ﹤0.01% of the portfolio, ranked #4581.
IFP Advisors first reported a position in CTKB in Q4 2022 and has held it in 7 quarters since. The position peaked at $8K in Q4 2022. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- IFP Advisors held 121 shares of Cytek Biosciences worth $721 as of Q3 2026.
- IFP Advisors sold 476 Cytek Biosciences shares in Q3 2026, an estimated $2.26K.
- Cytek Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4581 holding.
- IFP Advisors first reported a position in Cytek Biosciences in Q4 2022 and has held it in 7 quarters since.
- IFP Advisors's Cytek Biosciences position peaked at $8K in Q4 2022.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.